Cambridge Investment Research Advisors »

Gain Therapeutics shares owned by Cambridge Investment Research Advisors

Quarter-by-quarter ownership of Gain Therapeutics (GANX) shares owned by Cambridge Investment Research Advisors from 13F filings

Historical chart of Cambridge Investment Research Advisors investment in Gain Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Gain Therapeutics held by Cambridge Investment Research Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gain Therapeutics by Cambridge Investment Research Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $564k 319k 1.77
2025-06-30 $323k 180k 1.80
2025-03-31 $114k 60k 1.92
2024-12-31 $118k 55k 2.17

More positions owned by Cambridge Investment Research Advisors

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple Inc Com (AAPL)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corp Com (MSFT)
Amazon Com Inc Com (AMZN)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
SPDR S&p 500 Etf Tr Tr Unit (SPY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Capital Group Dividend Value Shs Creation Uni (CGDV)
Meta Platforms Inc Cl A (META)
Vanguard Index Fds Growth Etf (VUG)
Spdr Series Trust Portfolio S&P500 (SPLG)

View all positions for Cambridge Investment Research Advisors

Top funds holding Gain Therapeutics

Jones Financial Companies, L.L
DME Capital Management
Vanguard Group
Citadel Advisors
Geode Capital Management
Cambridge Investment Research Advisors
Marshall Wace
UBS Group
Renaissance Technologies
BlackRock
State Street Corporation
Northern Trust
Susquehanna International
Morgan Stanley
Jane Street

View all funds holding Gain Therapeutics